377 related articles for article (PubMed ID: 35461122)
1. No increased incidence of venous thrombosis or pulmonary embolism after SARS-CoV-2 vaccination in Germany.
Tanislav C; Rosenbauer J; Zingel R; Kostev K
Public Health; 2022 Jun; 207():14-18. PubMed ID: 35461122
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in Singapore.
Tu TM; Yi SJ; Koh JS; Saffari SE; Hoe RHM; Chen GJ; Chiew HJ; Tham CH; Seet CYH; Yong MH; Yong KP; Hui AC; Fan BE; Tan BY; Quek AML; Seet RCS; Yeo LLL; Tan K; Thirugnanam UN
JAMA Netw Open; 2022 Mar; 5(3):e222940. PubMed ID: 35297971
[TBL] [Abstract][Full Text] [Related]
3. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
4. Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
Hviid A; Hansen JV; Thiesson EM; Wohlfahrt J
Ann Intern Med; 2022 Apr; 175(4):541-546. PubMed ID: 35103482
[TBL] [Abstract][Full Text] [Related]
5. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
[TBL] [Abstract][Full Text] [Related]
6. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study.
Katsoularis I; Fonseca-Rodríguez O; Farrington P; Jerndal H; Lundevaller EH; Sund M; Lindmark K; Fors Connolly AM
BMJ; 2022 Apr; 377():e069590. PubMed ID: 35387772
[TBL] [Abstract][Full Text] [Related]
7. Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study.
McClymont E; Atkinson A; Albert A; Av-Gay G; Andrade J; Barrett J; Bogler T; Boucoiran I; Castillo E; D'Souza R; El-Chaâr D; Fadel S; Fell DB; Korchinski I; Kuret V; Ogilvie G; Poliquin V; Sadarangani M; Scott H; Snelgrove JW; Tunde-Byass M; Money D;
Vaccine; 2023 Nov; 41(48):7183-7191. PubMed ID: 37865598
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
[TBL] [Abstract][Full Text] [Related]
9. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
Goldshtein I; Nevo D; Steinberg DM; Rotem RS; Gorfine M; Chodick G; Segal Y
JAMA; 2021 Aug; 326(8):728-735. PubMed ID: 34251417
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
Husby A; Hansen JV; Fosbøl E; Thiesson EM; Madsen M; Thomsen RW; Sørensen HT; Andersen M; Wohlfahrt J; Gislason G; Torp-Pedersen C; Køber L; Hviid A
BMJ; 2021 Dec; 375():e068665. PubMed ID: 34916207
[TBL] [Abstract][Full Text] [Related]
11. Risk of venous thromboembolism after COVID-19 vaccination.
Houghton DE; Wysokinski W; Casanegra AI; Padrnos LJ; Shah S; Wysokinska E; Pruthi R; Ashrani A; Sridharan M; Baumann-Kreuziger L; McBane R; Padmanabhan A
J Thromb Haemost; 2022 Jul; 20(7):1638-1644. PubMed ID: 35398975
[TBL] [Abstract][Full Text] [Related]
12. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
13. Incidence of SARS-CoV-2 infection among previously infected or vaccinated employees.
Kojima N; Roshani A; Brobeck M; Baca A; Klausner JD
Int J Infect Dis; 2022 May; 118():21-23. PubMed ID: 35151852
[TBL] [Abstract][Full Text] [Related]
14. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.
Chang H; Rockman CB; Jacobowitz GR; Speranza G; Johnson WS; Horowitz JM; Garg K; Maldonado TS; Sadek M; Barfield ME
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):597-604. PubMed ID: 33039545
[TBL] [Abstract][Full Text] [Related]
15. Inactivated whole-virion SARS-CoV-2 vaccines and long-term clinical outcomes in patients with coronary atherosclerosis disease in China: a prospective cohort study.
Xu H; Zheng J; Zhao X; Zhou Q; Fan B; Wu H; Zhang S; Ge J
Cardiovasc Res; 2023 Jun; 119(6):1352-1360. PubMed ID: 36756815
[TBL] [Abstract][Full Text] [Related]
16. Association of Influenza Vaccination With SARS-CoV-2 Infection and Associated Hospitalization and Mortality Among Patients Aged 66 Years or Older.
Hosseini-Moghaddam SM; He S; Calzavara A; Campitelli MA; Kwong JC
JAMA Netw Open; 2022 Sep; 5(9):e2233730. PubMed ID: 36169955
[TBL] [Abstract][Full Text] [Related]
17. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
Chia PY; Ong SWX; Chiew CJ; Ang LW; Chavatte JM; Mak TM; Cui L; Kalimuddin S; Chia WN; Tan CW; Chai LYA; Tan SY; Zheng S; Lin RTP; Wang L; Leo YS; Lee VJ; Lye DC; Young BE
Clin Microbiol Infect; 2022 Apr; 28(4):612.e1-612.e7. PubMed ID: 34826623
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic events following Covid-19 vaccines compared to Influenza vaccines.
Vallone MG; Falcón AL; Castro HM; Ferraris A; Cantarella RF; Staneloni MI; Aliperti VI; Ferloni A; Mezzarobba D; Vázquez FJ; Ratti MFG
Eur J Intern Med; 2022 May; 99():82-88. PubMed ID: 35288031
[TBL] [Abstract][Full Text] [Related]
19. Risk of Noninfectious Uveitis after Coronavirus Disease 2019 Vaccination in a United States Claims Database.
Kumar A; Miller DC; Sun Y; Arnold BF; Acharya NR
Ophthalmology; 2023 Dec; 130(12):1269-1278. PubMed ID: 37480943
[TBL] [Abstract][Full Text] [Related]
20. Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased.
Diebold M; Locher E; Boide P; Enzler-Tschudy A; Faivre A; Fischer I; Helmchen B; Hopfer H; Kim MJ; Moll S; Nanchen G; Rotman S; Saganas C; Seeger H; Kistler AD
Kidney Int; 2022 Dec; 102(6):1409-1419. PubMed ID: 36096267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
